IL131617A0 - 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds - Google Patents

5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds

Info

Publication number: IL131617A0
Authority: IL; Israel
Prior art keywords: aminopyridol; trisubstituted; pyrimidine compounds; pyrimidine; compounds
Prior art date: 1997-04-16

Application number

IL13161798A

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-16

Filing date

1998-04-13

Publication date

2001-01-28

1998-04-13 Application filed by Abbott Lab filed Critical Abbott Lab

2001-01-28 Publication of IL131617A0 publication Critical patent/IL131617A0/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Transplantation (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IL13161798A 1997-04-16 1998-04-13 5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds IL131617A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84348497A	1997-04-16	1997-04-16
PCT/US1998/007201 WO1998046604A1 (en)	1997-04-16	1998-04-13	5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds

Publications (1)

Publication Number	Publication Date
IL131617A0 true IL131617A0 (en)	2001-01-28

Family

ID=25290123

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13161798A IL131617A0 (en)	1997-04-16	1998-04-13	5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds

Country Status (19)

Country	Link
EP (1)	EP0975633A1 (en)
JP (1)	JP2001520654A (en)
KR (1)	KR20010006462A (en)
CN (1)	CN1252069A (en)
AR (1)	AR012437A1 (en)
AU (1)	AU741033B2 (en)
BG (1)	BG103853A (en)
BR (1)	BR9809056A (en)
CA (1)	CA2286592A1 (en)
CO (1)	CO4940470A1 (en)
HU (1)	HUP0001443A3 (en)
IL (1)	IL131617A0 (en)
NO (1)	NO995035L (en)
NZ (1)	NZ337125A (en)
PL (1)	PL336265A1 (en)
SK (1)	SK140099A3 (en)
TR (1)	TR199902550T2 (en)
WO (1)	WO1998046604A1 (en)
ZA (1)	ZA983175B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001057040A1 (en) *	2000-02-03	2001-08-09	Abbott Laboratories	6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
CN100376571C (en)	2001-02-12	2008-03-26	霍夫曼-拉罗奇有限公司	6-substituted pyridopyrimidines
CN107744520A (en) *	2017-10-25	2018-03-02	南京多宝生物科技有限公司	Pyrimidines are preparing the application in promoting small bowel peristalsis medicine
CN112209924B (en) *	2019-07-09	2022-04-05	中国科学院天津工业生物技术研究所	selective adenosine A1 receptor antagonists
EP4343709B1 (en) *	2022-09-23	2024-10-30	Axis AB	Method and image-processing device for determining a probability value indicating that an object captured in a stream of image frames belongs to an object type

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB774094A (en) *	1953-01-02	1957-05-08	Wellcome Found	Improvements in or relating to pyrimidine compounds
IL112249A (en) *	1994-01-25	2001-11-25	Warner Lambert Co	Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

1998
- 1998-04-13 JP JP54408398A patent/JP2001520654A/en active Pending
- 1998-04-13 SK SK1400-99A patent/SK140099A3/en unknown
- 1998-04-13 WO PCT/US1998/007201 patent/WO1998046604A1/en not_active Ceased
- 1998-04-13 KR KR1019997009552A patent/KR20010006462A/en not_active Withdrawn
- 1998-04-13 NZ NZ337125A patent/NZ337125A/en unknown
- 1998-04-13 PL PL98336265A patent/PL336265A1/en unknown
- 1998-04-13 CA CA002286592A patent/CA2286592A1/en not_active Abandoned
- 1998-04-13 AU AU71080/98A patent/AU741033B2/en not_active Ceased
- 1998-04-13 EP EP98918091A patent/EP0975633A1/en not_active Withdrawn
- 1998-04-13 HU HU0001443A patent/HUP0001443A3/en unknown
- 1998-04-13 IL IL13161798A patent/IL131617A0/en unknown
- 1998-04-13 BR BR9809056-9A patent/BR9809056A/en not_active IP Right Cessation
- 1998-04-13 TR TR1999/02550T patent/TR199902550T2/en unknown
- 1998-04-13 CN CN98804117A patent/CN1252069A/en active Pending
- 1998-04-15 ZA ZA983175A patent/ZA983175B/en unknown
- 1998-04-15 AR ARP980101734A patent/AR012437A1/en unknown
- 1998-04-16 CO CO98020978A patent/CO4940470A1/en unknown
1999
- 1999-10-15 NO NO995035A patent/NO995035L/en not_active Application Discontinuation
- 1999-11-03 BG BG103853A patent/BG103853A/en unknown

Also Published As

Publication number	Publication date
CO4940470A1 (en)	2000-07-24
EP0975633A1 (en)	2000-02-02
TR199902550T2 (en)	2000-04-21
KR20010006462A (en)	2001-01-26
NO995035D0 (en)	1999-10-15
WO1998046604A1 (en)	1998-10-22
ZA983175B (en)	1998-10-21
AU741033B2 (en)	2001-11-22
PL336265A1 (en)	2000-06-19
NZ337125A (en)	2001-06-29
BR9809056A (en)	2000-08-01
BG103853A (en)	2000-06-30
AU7108098A (en)	1998-11-11
NO995035L (en)	1999-12-15
HUP0001443A2 (en)	2000-10-28
HUP0001443A3 (en)	2001-01-29
SK140099A3 (en)	2000-05-16
AR012437A1 (en)	2000-10-18
JP2001520654A (en)	2001-10-30
CN1252069A (en)	2000-05-03
CA2286592A1 (en)	1998-10-22

Publication	Publication Date	Title
ZA989767B (en)	2000-04-28	Novel compounds.
HRP980398B1 (en)	2002-06-30	5H-THIAZOLO /3,2-a/ PYRIMIDINE DERIVATIVES
ZA985323B (en)	1999-01-11	New compounds
ZA983177B (en)	1999-01-22	5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
DE59804842D1 (en)	2002-08-22	Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA9811503B (en)	2000-06-15	Novel compounds.
ZA9811758B (en)	2000-06-22	Novel compounds.
ZA989839B (en)	1999-04-29	New spirocyciic compounds
IL136500A0 (en)	2001-06-14	1,4-diazacycloheptane derivatives
ZA983736B (en)	1998-11-05	New compounds
IL131617A0 (en)	2001-01-28	5,6,7-Trisubstituted-4-aminopyridol ¬2,3-d¾ pyrimidine compounds
ZA982912B (en)	1998-10-09	6,7-disubstituted-4-aminopyrido [2,3-d] pyrimidine compounds
ZA98868B (en)	1999-08-03	Novel compounds.
AUPP003297A0 (en)	1997-11-20	4,5-diaryloxazole compounds
GB9704522D0 (en)	1997-04-23	Compounds
ZA981529B (en)	1998-09-03	Substituted 2,4-diaminopyrimidine
GB9702978D0 (en)	1997-04-02	Compounds
IL150715A0 (en)	2003-02-12	Substituted pyrimidines
HK1027096A (en)	2001-01-05	6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
HK1027095A (en)	2001-01-05	5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
EP0954316A4 (en)	2002-02-13	Pyrimidine derivatives
IL166937A (en)	2005-09-25	Uracil compounds
ZA982185B (en)	1999-09-16	Novel compounds.
ZA984303B (en)	1999-11-22	Novel compounds.
ZA982184B (en)	1999-09-16	Novel compounds.